Neoplasms (Cancer / Tumors)N-PELTPNCT07460570
Nurse-Led Culturally Adapted Palliative and End-of-Life Training for Oncology Nurses in Oman
A study testing N-PELTP Palliative and End-of-Life Training Program in people with Neoplasms (Cancer / Tumors) and Palliative Care, run by Sultan Qaboos University at 2 sites in Oman.
Trial summary
This study evaluated a nurse-led, culturally adapted training program in palliative and end-of-life care (N-PELTP) for oncology nurses in Oman. Nurses in the intervention group received the structured training program, while a comparison group continued usual practice during the same period. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Neoplasms (Cancer / Tumors), Palliative Care, Terminal Care
- What is being tested?
- N-PELTP Palliative and End-of-Life Training Program
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 189 participants
- Where
- 2 sitesOman
- Study dates
- 1 Apr 2025to 5 Jul 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Registered nurses working in participating oncology/cancer care settings in Oman
- Providing direct clinical care to patients with cancer
- Employed at the study site during the study period and expected to remain for the duration of the intervention and follow-up assessments
- Aged 18 years or older
- Able to read and understand the study materials and questionnaires
- Willing to participate and provide informed consent
Who cannot join
- Nursing students, interns, or non-registered nursing staff
- Nurses not providing direct patient care (e.g., administrative/managerial roles without bedside clinical duties)
- Nurses on extended leave during the intervention or follow-up period (e.g., annual leave, sick leave, maternity leave)
- Nurses who did not complete the baseline (pre-intervention) assessment
Trial locations and contacts
2 sites in 1 country.
Oman2 sites
Royal Hospital
Muscat, PC123
Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City
Muscat, PC123
About this study
Official title: Effectiveness of a Nurse-Led, Culturally Adapted Palliative and End-of-Life Training Program (N-PELTP) for Oncology Nurses: A Quasi-Experimental Controlled Study
This study evaluated a nurse-led, culturally adapted training program in palliative and end-of-life care (N-PELTP) for oncology nurses in Oman. Nurses in the intervention group received the structured training program, while a comparison group continued usual practice during the same period. Outcomes were assessed using questionnaires completed before and after the intervention to measure palliative care knowledge, attitudes toward caring for dying patients, self-reported palliative care practices, and communication-related outcomes. The goal of the study was to determine whether a culturally adapted educational program can improve oncology nurses' readiness to deliver palliative and end-of-life care.
Read the detailed description
Palliative and end-of-life care requires skilled nursing communication, symptom management knowledge, and culturally sensitive approaches to care. In many settings, oncology nurses report variable preparation and limited training opportunities in palliative and end-of-life care. This quasi-experimental controlled pretest-posttest study assessed the effectiveness of a nurse-led, culturally adapted palliative and end-of-life training program (N-PELTP) implemented in oncology settings in Oman.
Eligible participants were registered oncology nurses providing direct patient care. The intervention group participated in a structured training program delivered over a defined period, while a comparable control group did not receive the training during the study period. Outcomes were assessed using validated tools at baseline (pre-intervention) and after completion of the intervention (post-intervention). The primary objective was to evaluate change in palliative care knowledge. Secondary objectives included changes in attitudes toward caring for dying patients, self-reported palliative care practices, and communication outcomes.
- Conditions
- Neoplasms (Cancer / Tumors), Palliative Care, Terminal Care
- Being tested
- N-PELTP Palliative and End-of-Life Training Program
- Keywords
- Palliative care, End-of-life care, Oncology nurses, Nurse education, Training program, Attitudes toward death and dying, Knowledge, Communication skills, Quasi-experimental, Oman
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
N-PELTP Palliative and End-of-Life Training ProgramBehavioural
A nurse-led, culturally adapted palliative and end-of-life care education and training program for oncology nurses (N-PELTP). The program was delivered in a structured format over a defined training period and covered core palliative and end-of-life care competencies, including communication and care planning. Outcomes were assessed using standardized questionnaires at baseline (pre-intervention) and after completion of the training (post-intervention
| Study group | Role | What they receive |
|---|---|---|
| N-PELTP Training Program | Experimental | Participants received the nurse-led, culturally adapted palliative and end-of-life care training program (N-PELTP). Outcomes were assessed before and after the intervention using standardized questionnaires. Receives: Behavioral: N-PELTP Palliative and End-of-Life Training Program |
| Control (Usual Practice) | No intervention | Participants continued usual practice during the study period and did not receive the N-PELTP training during the intervention phase. Outcomes were assessed at the same time points as the intervention group. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Attitude Toward Care of the Dying Score (Frommelt Attitude Toward Care of the Dying Scale, Form B; FATCOD-B)
Total score on the Frommelt Attitude Toward Care of the Dying Scale, Form B (FATCOD-B), a 30-item instrument rated on a 5-point Likert scale. Total score range: 30 to 150. Higher scores indicate more positive attitudes toward caring for dying patients.
Measured: Baseline (pre-intervention) and 2 weeks post-intervention
Palliative and End-of-Life Care Knowledge Score (Palliative and End-of-Life Care Knowledge Questionnaire; PEACE-Q)
Total score on the Palliative and End-of-Life Care Knowledge Questionnaire (PEACE-Q), a 34-item true/false questionnaire. Total score range: 0 to 34. Higher scores indicate greater palliative/end-of-life care knowledge.
Measured: Baseline (pre-intervention) and immediately post-intervention
Palliative Care Self-Reported Practice Score (Palliative Care Self-Reported Practices Scale; PCPS)
Total score on the Palliative Care Self-Reported Practices Scale (PCPS), an 18-item scale rated from 1 (not at all) to 5 (always). Total score range: 18 to 90. Higher scores indicate more frequent palliative care practices.
Measured: Baseline (pre-intervention) and 2 weeks post-intervention
Communication Practice Score (Communication Domain of PCPS)
Communication practice score derived from the communication domain of the Palliative Care Self-Reported Practices Scale (PCPS). Items are rated from 1 (not at all) to 5 (always). Domain score range: 1 to 5 when calculated as a mean item score. Higher scores indicate more frequent/better communication practices in palliative/end-of-life care contexts.
Measured: Baseline (pre-intervention) and 2 weeks post-intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Mar 2026
- Study start1 Apr 2025
- Primary completion5 Jul 2025
- Study completion5 Jul 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Neoplasms (Cancer / Tumors)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 189 participants (actual)
Sponsor and investigators
- Lead sponsor
- Sultan Qaboos University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07460570
- Sponsor's protocol ID
- N-PELTP-ON-OM-2025
- Other IDs
- N-PELTP-ON-OM-2025
- Acronym
- N-PELTP
- Status last verified
- Mar 2026
- First submitted
- 1 Mar 2026
- Last updated
- 10 Mar 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared publicly due to participant confidentiality and institutional/ethical restrictions. De-identified summary data may be made available from the corresponding author on reasonable request, subject to ethics approval where applicable.
Study at a glance
From the registry record, last updated by the sponsor on 10 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of a Nurse-Led, Culturally Adapted Palliative and End-of-Life Training Program (N-PELTP) for Oncology Nurses: A Quasi-Experimental Controlled Study
- ClinicalTrials.gov ID
- NCT07460570
- Acronym / sponsor ID
- N-PELTP / N-PELTP-ON-OM-2025
- Conditions
- Neoplasms (Cancer / Tumors), Palliative Care, Terminal Care
- Keywords
- Palliative care, End-of-life care, Oncology nurses, Nurse education, Training program, Attitudes toward death and dying, Knowledge, Communication skills
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 189 participants (actual)
- Lead sponsor
- Sultan Qaboos UniversityUniversity, hospital or other
- Study start
- 1 Apr 2025 (actual)
- Primary completion
- 5 Jul 2025 (actual)
- Study completion
- 5 Jul 2025 (actual)
- First posted
- 10 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study evaluated a nurse-led, culturally adapted training program in palliative and end-of-life care (N-PELTP) for oncology nurses in Oman. Nurses in the intervention group received the structured training program, while a comparison group continued usual practice during the same period. Outcomes were assessed using questionnaires completed before and after the intervention to measure palliative care knowledge, attitudes toward caring for dying patients, self-reported palliative care practices, and communication-related outcomes. The goal of the study was to determine whether a culturally adapted educational program can improve oncology nurses' readiness to deliver palliative and end-of-life care.
Detailed description
Palliative and end-of-life care requires skilled nursing communication, symptom management knowledge, and culturally sensitive approaches to care. In many settings, oncology nurses report variable preparation and limited training opportunities in palliative and end-of-life care. This quasi-experimental controlled pretest-posttest study assessed the effectiveness of a nurse-led, culturally adapted palliative and end-of-life training program (N-PELTP) implemented in oncology settings in Oman.
Eligible participants were registered oncology nurses providing direct patient care. The intervention group participated in a structured training program delivered over a defined period, while a comparable control group did not receive the training during the study period. Outcomes were assessed using validated tools at baseline (pre-intervention) and after completion of the intervention (post-intervention). The primary objective was to evaluate change in palliative care knowledge. Secondary objectives included changes in attitudes toward caring for dying patients, self-reported palliative care practices, and communication outcomes.
Study design
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| N-PELTP Training Program | Experimental | Behavioral: N-PELTP Palliative and End-of-Life Training ProgramParticipants received the nurse-led, culturally adapted palliative and end-of-life care training program (N-PELTP). Outcomes were assessed before and after the intervention using standardized questionnaires. |
| Control (Usual Practice) | No intervention | –Participants continued usual practice during the study period and did not receive the N-PELTP training during the intervention phase. Outcomes were assessed at the same time points as the intervention group. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (6 listed)
- Registered nurses working in participating oncology/cancer care settings in Oman
- Providing direct clinical care to patients with cancer
- Employed at the study site during the study period and expected to remain for the duration of the intervention and follow-up assessments
- Aged 18 years or older
- Able to read and understand the study materials and questionnaires
Key exclusion criteria (4 listed)
- Nursing students, interns, or non-registered nursing staff
- Nurses not providing direct patient care (e.g., administrative/managerial roles without bedside clinical duties)
- Nurses on extended leave during the intervention or follow-up period (e.g., annual leave, sick leave, maternity leave)
- Nurses who did not complete the baseline (pre-intervention) assessment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| N-PELTP Palliative and End-of-Life Training ProgramA nurse-led, culturally adapted palliative and end-of-life care education and training program for oncology nurses (N-PELTP). The program was delivered in a structured format over a defined training period and covered core palliative and end-of-life care competencies, including communication and care planning. Outcomes were assessed using standardized questionnaires at baseline (pre-intervention) and after completion of the training (post-intervention | Behavioural | N-PELTP Training Program |
Primary outcome
Attitude Toward Care of the Dying Score (Frommelt Attitude Toward Care of the Dying Scale, Form B; FATCOD-B)
Time frame: Baseline (pre-intervention) and 2 weeks post-intervention
Total score on the Frommelt Attitude Toward Care of the Dying Scale, Form B (FATCOD-B), a 30-item instrument rated on a 5-point Likert scale. Total score range: 30 to 150. Higher scores indicate more positive attitudes toward caring for dying patients.
Palliative and End-of-Life Care Knowledge Score (Palliative and End-of-Life Care Knowledge Questionnaire; PEACE-Q)
Time frame: Baseline (pre-intervention) and immediately post-intervention
Total score on the Palliative and End-of-Life Care Knowledge Questionnaire (PEACE-Q), a 34-item true/false questionnaire. Total score range: 0 to 34. Higher scores indicate greater palliative/end-of-life care knowledge.
Palliative Care Self-Reported Practice Score (Palliative Care Self-Reported Practices Scale; PCPS)
Time frame: Baseline (pre-intervention) and 2 weeks post-intervention
Total score on the Palliative Care Self-Reported Practices Scale (PCPS), an 18-item scale rated from 1 (not at all) to 5 (always). Total score range: 18 to 90. Higher scores indicate more frequent palliative care practices.
Communication Practice Score (Communication Domain of PCPS)
Time frame: Baseline (pre-intervention) and 2 weeks post-intervention
Communication practice score derived from the communication domain of the Palliative Care Self-Reported Practices Scale (PCPS). Items are rated from 1 (not at all) to 5 (always). Domain score range: 1 to 5 when calculated as a mean item score. Higher scores indicate more frequent/better communication practices in palliative/end-of-life care contexts.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Mar 2026.
- Individual participant dataSharing planned: No. Individual participant data will not be shared publicly due to participant confidentiality and institutional/ethical restrictions. De-identified summary data may be made available from the corresponding author on reasonable request, subject to ethics approval where applicable.
Related trials for Neoplasms (Cancer / Tumors)
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing N-PELTP Palliative and End-of-Life Training Program in people with Neoplasms (Cancer / Tumors) and Palliative Care, run by Sultan Qaboos University at 2 sites in Oman.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Oman. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Attitude Toward Care of the Dying Score (Frommelt Attitude Toward Care of the Dying Scale, Form B; FATCOD-B) (time frame: Baseline (pre-intervention) and 2 weeks post-intervention). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Mar 2026.